Meet with SDIX at Medica

Dear Customer:

Please join SDIX at Messe center, Dusseldorf this November and learn about our innovative antibody development technology, and how it enables the clinical assay development process. 

Wednesday, Nov 14, 2012
Room 812, Hall 8b

Session I:
Design and Development of Antibodies to Complex Protein Targets for Clinical Assay Applications (Starting at 14:00)

Abstract: Knowledge of antigen and antibody structure as well as the intended assay format and application dictate the strategy of antigen design, immunization and antibody screening protocols.  Genomic Antibody TechnologyTM (GAT) is designed for development of target specific antibodies that recognize conformational epitopes in critical assay formats such as sandwich immunoassays. Antigen and antibody design strategies useful for different assay formats, classes of protein targets, and clinically-relevant protein epitopes are discussed.

Session II:
Can 2+2=22?  Master the equations that create the success in clinical reagent development and manufacturing (Starting at 15:30)

Abstract:  Antibodies are the critical component of immunoassays.  Availability of quality antibodies on a regular basis with batch-to-batch consistency is a key requirement for IVD companies. In this session we will discuss the key success factors of commercial scale antibody manufacturing. The topics discussed will include: selection of antibodies (mAb vs. pAb), cell line optimization, ideal production methods, immunization protocol development, polyclonal bulk manufacturing, antibody customization, and the advantages of just-in-time inventory.

Meeting Appointments:

Our technical team is available for meetings during the show. For scheduling a meeting with our scientists, please contact me at with your availability. If you prefer, you can stop by our booth (Hall 01/F10) at the show and speak with one of our colleagues. For other product-related queries, please contact

Refreshments will be provided. Please register here for the seminars.